This article was automatically translated from the original Turkish version.
+2 More
Ellagic acid is a polyphenolic compound naturally found in plants. It was first identified in 1905 and has been found to occur in high concentrations particularly in fruits seeds and peel tissues. It is produced through the hydrolysis of hydrolysable tannins such as ellagitannins. Due to its polyphenolic structure it exhibits strong antioxidant properties. It is extensively studied in the food pharmaceutical and cosmetic industries due to its potential biological effects.
Ellagic acid is abundant particularly in fruits and nuts. Red and purple fruits such as pomegranate raspberry blackberry strawberry and blueberry are significant sources. It is also present in nuts such as walnut hazelnut and chestnut in the form of ellagitannins. Pomegranate peel is one of the richest plant sources of ellagic acid. Additionally it has been detected in the leaves and peels of certain tropical plants.
Ellagic acid is known for its ability to neutralize free radicals. Its phenolic hydroxyl groups prevent oxidative damage to DNA lipids and proteins by reducing oxidative stress. This property gives it potential as a food additive. It is also suggested to assist in the prevention of chronic diseases associated with oxidative stress.
Various in vitro and in vivo studies have demonstrated that ellagic acid can suppress tumor cell proliferation. It acts through mechanisms such as reducing DNA mutations activating apoptotic pathways and inhibiting angiogenesis. It has been particularly studied in colon prostate breast and skin cancer cells. Although human study results remain limited its anticancer potential makes it a subject of intense research.
Ellagic acid has been reported to inhibit the growth of bacteria and fungi. Different levels of sensitivity have been observed against both Gram-positive and Gram-negative bacteria. It has also been shown to exhibit antifungal activity against certain pathogenic fungi. These effects are significant for its potential use as a natural preservative in food and cosmetic products.
Ellagic acid has been shown to reduce the production of inflammatory cytokines and suppress the NF-κB pathway. This suggests it may provide complementary effects in the treatment of chronic inflammatory diseases such as arthritis and inflammatory bowel diseases. Animal model studies have yielded promising results.
Thanks to its polyphenolic structure ellagic acid can inhibit low-density lipoprotein (LDL) oxidation. It contributes to vascular health by preserving endothelial function. Evidence suggests it has blood pressure regulatory effects. It is thought to play a role in the long-term prevention of atherosclerosis and coronary heart disease.
Due to its natural antioxidant properties ellagic acid can be used as a food additive to extend shelf life. It plays an inhibitory role against oxidation particularly in meat products fats and fruit-based products. It is also added as a supportive ingredient in functional foods due to its health benefits.
Ellagic acid is used in skin-lightening and anti-spot products by suppressing melanin production in the skin. Its antioxidant property carries potential for reducing signs of aging and preventing UV-induced skin damage. For this reason it is also used in the formulation of sunscreens and anti-aging products.
Due to its anticancer antiinflammatory and hepatoprotective effects ellagic acid is being investigated in drug development studies. Promising results have been obtained particularly in research on colon and prostate cancer. It is also emerging as a hepatoprotective agent due to its ability to reduce liver damage. Clinical research is still in the experimental stage.
Ellagic acid is added to bioplastics and active food packaging materials as an antimicrobial agent. It also has potential applications in environmental cleaning and heavy metal removal due to its ability to form complexes with metal ions. It is being evaluated as an active component in nanotechnology-based formulations.
The bioavailability of ellagic acid is limited due to poor solubility in the intestine and rapid metabolism. It is converted by the gut microbiota into urolithins. Urolithins are metabolites responsible for most of ellagic acid’s biological effects. This is a crucial factor in understanding its pharmacokinetics and pharmacodynamics. Human bioavailability studies are ongoing.
Ellagic acid is generally considered a safe compound. High doses have been reported to cause gastrointestinal discomfort. Animal studies have shown low toxicity levels. However further clinical research is needed to establish safety for long-term use and high doses. There are no legal restrictions on its use as a food additive.
Recent studies have focused on ellagic acid’s effects on human health primarily through its urolithin metabolites. Gut microbiota diversity leads to individual variations in urolithin production profiles which can determine personal health outcomes. Evidence suggests it may exhibit synergistic effects when combined with chemotherapy drugs in cancer treatment. Intensive research is also being conducted to enhance its bioavailability using nanotechnology-based delivery systems. At the clinical level the effects of ellagic acid supplements on skin health cardiovascular system and liver diseases are still under evaluation.
Chemical Structure and Physical Properties
Natural Sources
Biological Activities
Antioxidant Activity
Anticancer Effects
Antimicrobial Effects
Antiinflammatory Effects
Cardiovascular Protection
Medical and Industrial Applications
Use in the Food Industry
Cosmetics and Dermatology
Pharmaceutical and Medical Uses
Industrial Technologies
Metabolism and Bioavailability
Safety and Toxicity
Current Research